Olivia Zeiden

Now Hiring: Communications Program Assistant

Program Assistant –Communications Mission: Cure is a nonprofit founded in 2017 to improve the health and lives of people affected by costly diseases with poor and inequitable patient outcomes, starting with Pancreatitis, a painful inflammatory disease with no effective treatment. We bring a sense of urgency, efficiency, and innovation to the disease-curing ecosystem. Role Summary:

Now Hiring: Communications Program Assistant Read More »

Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis

December 2025 — Mission: Cure is pleased to announce a collaboration with Cibus Therapeutics and Greenstone Biosciences, two biotechnology companies working together developing next-generation treatments for pancreatic and gastrointestinal diseases. This partnership reflects Mission: Cure’s commitment to keeping the patient community informed about emerging science and supporting efforts to advance new therapies for chronic pancreatitis.

Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis Read More »

A Community for People Navigating High Triglycerides

High triglyceride levels can affect people in different ways. High triglycerides often don’t cause symptoms, so many people don’t realize their levels are elevated until a blood test. When triglycerides get extremely high, they can sometimes cause physical signs (like small yellow skin bumps) and can raise the risk of serious complications, including acute pancreatitis

A Community for People Navigating High Triglycerides Read More »

FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS)

We have some exciting news for people living with pancreatitis caused by the FCS genetic mutation. The FDA has approved REDEMPLO® (plozasiran), a new treatment from Arrowhead Pharmaceuticals that lowers triglycerides and reduces acute pancreatitis attacks in adults with Familial Chylomicronemia Syndrome (FCS). This is an important step for people with FCS and a meaningful

FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS) Read More »

New Resource: Managing Life with FCS – A Peer Support Toolbox

High triglycerides are one of the leading causes of pancreatitis, and for some people, extremely high levels can be caused by a rare genetic condition called Familial Chylomicronemia Syndrome (FCS). We’re excited to share a new resource created for and by the FCS community in partnership with Arrowhead Pharmaceuticals. This was specifically designed for people

New Resource: Managing Life with FCS – A Peer Support Toolbox Read More »

Scroll to Top

Before You Go

Get Updates in Your Inbox

Stay up-to-date on the latest Mission: Cure news and developments in pancreatitis care.







I am a...: